Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2011-07-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第三届监事会第九次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2011 semi-annual report. It states that the Supervisory Board has reviewed and approved the half-year report, confirming its compliance and accuracy. The document itself is not the semi-annual report but a formal announcement of the Supervisory Board's meeting resolution approving that report. Given the short length (759 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than the actual Interim/Quarterly Report (IR).
2011-07-21 Chinese
2011年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2011 年半年度报告" which translates to "2011 Semi-Annual Report". It contains detailed financial data for the first half of the year (1-6 months), including balance sheet items, income statement items, cash flow data, shareholder information, management discussion, and investment details. The document is comprehensive and includes actual financial statements and substantive financial analysis for a period shorter than a full fiscal year. It is not a brief announcement or a certification letter but a full interim report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2011
2011-07-21 Chinese
第三届董事会第十次会议的公告
Board/Management Information Classification · 95% confidence The document is a resolution from the third board meeting of the company 嘉事堂药业股份有限公司 dated July 19, 2011. It specifically mentions the approval of the company's 2011 semi-annual report. The document is a board meeting announcement or resolution rather than the semi-annual report itself. It contains no financial statements or detailed financial data, only the approval decision. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2011-07-21 Chinese
2010年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2010 annual equity distribution plan approved at the 2010 Annual General Meeting. It details dividend payments, share capital increase through capital reserve conversion, record dates, and other procedural information related to shareholder rights distribution. The document does not contain financial statements or detailed financial performance data but focuses on the dividend and share distribution specifics. This fits the definition of a Notice of Dividend Amount (DIV) rather than a full Annual Report or other financial report types.
2011-06-28 Chinese
2010年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2010 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It details the legality and compliance of the AGM's convening, attendance, voting procedures, and results. The document references the AGM date (May 5, 2011) and the agenda items discussed and approved at the meeting. It does not contain financial statements or detailed financial performance data but focuses on the legal aspects of the AGM process and resolutions. Given the content and purpose, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, including legal opinions related to the meeting.
2011-05-06 Chinese
2010年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a 2010 Annual General Meeting (AGM) resolution announcement for 嘉事堂药业股份有限公司. It details the meeting date, attendance, agenda items, and voting results on various reports and proposals related to the 2010 fiscal year. The content focuses on the resolutions passed at the AGM, including approval of the annual report, financial statements, and other corporate matters. There is no detailed financial data or full report text, but rather the official announcement of the voting results and meeting proceedings. The document length is 2297 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2011-05-06 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.